If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Maria Giovanna Dal Bello is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

ADP ribose polymerase inhibitors for treating non-small cell lung cancer: new additions to the pharmacotherapeutic armamentarium

Rossi, G., Zullo, L., Cerbone, L., Coco, S., Longo, L., Tagliamento, M., Dal Bello, M. G., Boccardo, S., Alama, A. & Genova, C., Jan 1 2020, (Accepted/In press) In : Expert Opinion on Pharmacotherapy.

Research output: Contribution to journalReview article

  • Open Access
  • Precision medicine for NSCLC in the era of immunotherapy: New biomarkers to select the most suitable treatment or the most suitable patient

    Rossi, G., Russo, A., Tagliamento, M., Tuzi, A., Nigro, O., Vallome, G., Sini, C., Grassi, M., Dal Bello, M. G., Coco, S., Longo, L., Zullo, L., Tanda, E. T., Dellepiane, C., Pronzato, P. & Genova, C., May 2020, In : Cancers. 12, 5, 1125.

    Research output: Contribution to journalReview article

    Open Access
  • Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment

    Bonaventura, A., Grossi, F., Carbone, F., Vecchié, A., Minetti, S., Bardi, N., Elia, E., Ansaldo, A. M., Ferrara, D., Rijavec, E., Dal Bello, M. G., Rossi, G., Biello, F., Tagliamento, M., Alama, A., Coco, S., Spallarossa, P., Dallegri, F., Genova, C. & Montecucco, F., Jan 1 2020, (Accepted/In press) In : Clinical and Translational Oncology.

    Research output: Contribution to journalArticle